Sabby Management’s Kyntra Bio KYNB Stock Holding History

Sabby Management’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,186	Closed	-$1.22M	–	127
2020 Q3	$1.22M	Sell	1,186 -156	-12%	-$168K	0.18%	58
2020 Q2	$1.36M	Buy	+1,342	New	+$1.25M	0.27%	39
2019 Q2	–	Sell	-528	Closed	-$717K	–	96
2019 Q1	$717K	Sell	528 -1,289	-71%	-$1.75M	0.34%	23
2018 Q4	$2.1M	Buy	1,817 +1,336	+278%	+$1.5M	0.46%	27
2018 Q3	$730K	Buy	481 +61	+15%	+$93.9K	0.09%	65
2018 Q2	$657K	Buy	+420	New	+$548K	0.1%	75
2016 Q4	–	Sell	-2,907	Closed	-$1.45M	–	309
2016 Q3	$1.5M	Sell	2,907 -984	-25%	-$464K	0.06%	153
2016 Q2	$1.6M	Sell	3,891 -473	-11%	-$217K	0.08%	123
2016 Q1	$2.32M	Buy	+4,364	New	+$2.17M	0.12%	88
2015 Q4	–	Sell	-944	Closed	-$517K	–	339
2015 Q3	$517K	Sell	944 -2,980	-76%	-$1.81M	0.02%	290
2015 Q2	$2.31M	Buy	3,924 +2,388	+155%	+$1.39M	0.08%	153
2015 Q1	$1.21M	Buy	+1,536	New	+$1.19M	0.05%	178

Other funds holding KYNB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Sabby Management's KYNB Position: Q4 2020 in Review

Sabby Management sold out of Kyntra Bio (KYNB) in Q4 2020, closing a stake of 1,186 shares — an estimated $1.22M sold.

Sabby Management first reported a position in KYNB in Q1 2015 and held it in 12 quarters. The position peaked at $2.32M in Q1 2016. 207 funds tracked by Wall St. Rank hold KYNB as of Q4 2020.

Sabby Management reported no remaining Kyntra Bio position as of Q4 2020 after selling out during the quarter.
Sabby Management sold 1,186 Kyntra Bio shares in Q4 2020, an estimated $1.22M.
Sabby Management first reported a position in Kyntra Bio in Q1 2015 and held it in 12 quarters.
Sabby Management's Kyntra Bio position peaked at $2.32M in Q1 2016.
207 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2020.

Based on Sabby Management's 13F filing for Q4 2020, filed 16 Feb 2021.